[1] |
祝双双, 李春明. 口腔鳞状细胞癌预后评估的研究进展[J]. 现代口腔医学杂志, 2018, 32(4): 234-236, 241.
|
[2] |
Chinn SB, Myers JN. Oral cavity carcinoma: Current management, controversies, and future directions[J]. J Clin Oncol, 2015, 33(29): 3269-3276.
doi: 10.1200/JCO.2015.61.2929
pmid: 26351335
|
[3] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
[4] |
Ozbek S, Balasubramanian PG, Chiquet-Ehrismann R, et al. The evolution of extracellular matrix[J]. Mol Biol Cell, 2010, 21(24): 4300-4305.
doi: 10.1091/mbc.E10-03-0251
pmid: 21160071
|
[5] |
Theocharis AD, Skandalis SS, Gialeli C, et al. Extracellular matrix structure[J]. Adv Drug Deliv Rev, 2016, 97: 4-27.
|
[6] |
陈洁, 陈众博, 张筠, 等. 细胞外基质在肿瘤发展及治疗中的作用[J]. 生命的化学, 2022, 42(3): 385-393.
|
[7] |
Grossman M, Ben-Chetrit N, Zhuravlev A, et al. Tumor cell invasion can be blocked by modulators of collagen fibril alignment that control assembly of the extracellular matrix[J]. Cancer Res, 2016, 76(14): 4249-4258.
doi: 10.1158/0008-5472.CAN-15-2813
pmid: 27221706
|
[8] |
Iozzo RV, Schaefer L. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans[J]. Matrix Biol, 2015, 42: 11-55.
doi: 10.1016/j.matbio.2015.02.003
pmid: 25701227
|
[9] |
Tzanakakis G, Giatagana EM, Kuskov A, et al. Proteoglycans in the pathogenesis of hormone-dependent cancers: Mediators and effectors[J]. Cancers, 2020, 12(9): 2401.
|
[10] |
Blochberger TC, Cornuet PK, Hassell JR. Isolation and partial characterization of lumican and decorin from adult chicken corneas. A keratan sulfate-containing isoform of decorin is developmentally regulated[J]. J Biol Chem, 1992, 267(29): 20613-20619.
pmid: 1400383
|
[11] |
Weber IT, Harrison RW, Iozzo RV. Model structure of decorin and implications for collagen fibrillogenesis[J]. J Biol Chem, 1996, 271(50): 31767-31770.
doi: 10.1074/jbc.271.50.31767
pmid: 8943211
|
[12] |
Saika S, Miyamoto T, Tanaka S, et al. Response of lens epithelial cells to injury: Role of lumican in epithelial-mesenchymal transition[J]. Invest Ophthalmol Vis Sci, 2003, 44(5): 2094-2102.
|
[13] |
Paracuellos P, Kalamajski S, Bonna A, et al. Structural and functional analysis of two small leucine-rich repeat proteoglycans, fibromodulin and chondroadherin[J]. Matrix Biol, 2017, 63: 106-116.
doi: S0945-053X(17)30015-X
pmid: 28215822
|
[14] |
Kalamajski S, Bihan D, Bonna A, et al. Fibromodulin interacts with collagen cross-linking sites and activates lysyl oxidase[J]. J Biol Chem, 2016, 291(15): 7951-7960.
doi: 10.1074/jbc.M115.693408
pmid: 26893379
|
[15] |
Lee EJ, Jan AT, Baig MH, et al. Fibromodulin: A master regulator of myostatin controlling progression of satellite cells through a myogenic program[J]. FASEB J, 2016, 30(8): 2708-2719.
doi: 10.1096/fj.201500133R
pmid: 27069062
|
[16] |
Jian J, Zheng Z, Zhang K, et al. Fibromodulin promoted in vitro and in vivo angiogenesis[J]. Biochem Biophys Res Commun, 2013, 436(3): 530-535.
|
[17] |
Lu YP, Ishiwata T, Kawahara K, et al. Expression of lumican in human colorectal cancer cells[J]. Pathol Int, 2002, 52(8): 519-526.
pmid: 12366811
|
[18] |
Chen L, Zhang YX, Zuo YJ, et al. Lumican expression in gastric cancer and its association with biological behavior and prognosis[J]. Oncol Lett, 2017, 14(5): 5235-5240.
doi: 10.3892/ol.2017.6842
pmid: 29098025
|
[19] |
Khan FU, Owusu-Tieku NYG, Dai XY, et al. Wnt/β-catenin pathway-regulated fibromodulin expression is crucial for breast cancer metastasis and inhibited by aspirin[J]. Front Pharmacol, 2019, 10: 1308.
doi: 10.3389/fphar.2019.01308
pmid: 31824307
|
[20] |
Matsushima N, Ohyanagi T, Tanaka T, et al. Super-motifs and evolution of tandem leucine-rich repeats within the small proteoglycans—biglycan, decorin, lumican, fibromodulin, PRELP, keratocan, osteoadherin, epiphycan, and osteoglycin[J]. Proteins, 2000, 38(2): 210-225.
pmid: 10656267
|
[21] |
Antonsson P, Heinegård D, Oldberg A. Structure and deduced amino acid sequence of the human fibromodulin gene[J]. Biochim Biophys Acta, 1993, 1174(2): 204-206.
pmid: 8357838
|
[22] |
Garusi E, Rossi S, Perris R. Antithetic roles of proteoglycans in cancer[J]. Cell Mol Life Sci, 2012, 69(4): 553-579.
doi: 10.1007/s00018-011-0816-1
pmid: 21964924
|
[23] |
El-Naggar AK, Chan JKC, Grandis JR, et al. WHO classi fication of head and neck tumours[M]. 4th ed. Lyon: IARC Press, 2017: 110-111.
|
[24] |
Huang SH, O'Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer[J]. Curr Treat Options Oncol, 2017, 18(7): 40.
|
[25] |
Brocklehurst PR, Baker SR, Speight PM. Oral cancer screening: What have we learnt and what is there still to achieve?[J]. Future Oncol, 2010, 6(2): 299-304.
doi: 10.2217/fon.09.163
pmid: 20146588
|
[26] |
Appunni S, Anand V, Khandelwal M, et al. Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer[J]. Clin Chim Acta, 2019, 491: 1-7.
doi: S0009-8981(19)30003-8
pmid: 30629950
|
[27] |
Funderburgh JL, Funderburgh ML, Hevelone ND, et al. Sequence, molecular properties, and chromosomal mapping of mouse lumican[J]. Invest Ophthalmol Vis Sci, 1995, 36(11): 2296-2303.
|
[28] |
Nikitovic D, Papoutsidakis A, Karamanos NK, et al. Lumican affects tumor cell functions, tumor-ECM interactions, angiogenesis and inflammatory response[J]. Matrix Biol, 2014, 35: 206-214.
doi: 10.1016/j.matbio.2013.09.003
pmid: 24060754
|
[29] |
段绍毅, 王君辅, 邱越, 等. Lumican调控FAK信号通路对胃癌AGS细胞增殖、侵袭和迁移的影响[J]. 广西医科大学学报, 2021, 38(4): 676-681.
|
[30] |
Zang YQ, Dong QP, Lu Y, et al. Lumican inhibits immune escape and carcinogenic pathways in colorectal adenocarcinoma[J]. Aging, 2021, 13(3): 4388-4408.
|
[31] |
Zhou K, Ge MJ. Effect of lumican gene over-expression on proliferation of lung adenocarcinoma cell A549 and its mechanism[J]. Chin J Cell Mol Immunol, 2013, 29(5): 492-495, 497.
|
[32] |
Ishiwata T, Cho K, Kawahara K, et al. Role of lumican in cancer cells and adjacent stromal tissues in human pancreatic cancer[J]. Oncol Rep, 2007, 18(3): 537-543.
pmid: 17671699
|
[33] |
Lončar-Brzak B, Klobučar M, Veliki-Dalić I, et al. Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential[J]. Clin Oral Investig, 2018, 22(2): 1071-1082.
|
[34] |
Karamanou K, Franchi M, Proult I, et al. Lumican inhibits in vivo melanoma metastasis by altering matrix-effectors and invadopodia markers[J]. Cells, 2021, 10(4): 841.
|
[35] |
王佩瑶, 卢晓梅. Lumican在肿瘤中表达及作用的相关研究进展[J]. 现代肿瘤医学, 2015, 23(9): 1291-1295.
|
[36] |
Al-Qattan MM, Al-Qattan AM. Fibromodulin: Structure, physiological functions, and an emphasis on its potential clinical applications in various diseases[J]. J Coll Physicians Surg Pak, 2018, 28(10): 783-790.
doi: 3022
pmid: 30266125
|
[37] |
Reyes N, Benedetti I, Bettin A, et al. The small leucine rich proteoglycan fibromodulin is overexpressed in human prostate epithelial cancer cell lines in culture and human prostate cancer tissue[J]. Cancer Biomark, 2016, 16(1): 191-202.
doi: 10.3233/CBM-150555
pmid: 26600400
|
[38] |
Mondal B, Patil V, Shwetha SD, et al. Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration[J]. Oncogene, 2017, 36(1): 71-83.
doi: 10.1038/onc.2016.176
pmid: 27212030
|
[39] |
Svensson L, Närlid I, Oldberg A. Fibromodulin and lumican bind to the same region on collagen typeⅠfibrils[J]. FEBS Lett, 2000, 470(2): 178-182.
doi: 10.1016/s0014-5793(00)01314-4
pmid: 10734230
|